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Primary epididymal lymphomas are very rare condition, only 6 case report was published. In 4 of them,
initial presentation was non-tender, continuous growth of testis. It can be misdiagnosed with epididy-
mitis, 5 of them was treated by antibiotics before surgery. One patients treated by surgery another 5
makes neoadjuvant therapy, 2 of radiotherapy 3 of chemotherapy. Only one man died after treatment.
This case is about 54-year male patients, diagnosed by diffuse large B-cell lymphoma, who treated by
surgery and neoadjuvant chemotherapy combined with radiotherapy.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Malignant epididymal tumors are extremely rare, with a
maximum incidence of 0.03% of all male cancers.1 Only few primary
lymphoma in epididymis were reported.2e7 The age of these pa-
tients ranged from 20 to 73 years, and all were primarily treated
with surgical excision of the testis with epididymis. Except one
case,6 neoadjuvant chemotherapy or radiotherapy was performed.
Five of 6 patients showed no evidence of disease after treatment
and one 68-year-old man5 died after treatment.
In this report, we present a case of primary malignant lym-
phoma in epididymis consisting of diffuse large B-cell components.Case presentation
A 54-year-old man presented with painless right scrotal
swelling. The swelling had started 1 month ago during which it
increased in size. He initially visited the local clinic where he was
prescribed oral antibiotics for a week; however, the swelling
continued to grow in size. Finally, he presented at our clinic for an
evaluation. The patient’s history was noted and physical examina-
tionwas performed; therewere no symptoms or signs such as fever,
chills, testicular pain, or night sweating. A ﬁrm, non-tender, plum-
sized mass was palpable in the right scrotal area; it moved freelylogy, Seoul Metropolitan
ical Center, 39, Boramae-gil,
0 2393; fax: þ82 2 831 2826.
Inc. This is an open access article ubut was conﬁned to the epididymis. Both the testes in the scrotum
were easily palpable and were about 19 ml in size. There were no
enlarged lymph nodes in the inguinal area.
Ultrasonography revealed a 6  5 cm heterogeneous echoic
lesion in the right epididymis, which was well separated from the
testis. A small hydrocele was observed in the right hemiscrotum,
which was ruled out due to reactive change. A color Doppler image
revealed increased vascularity in the epididymis (Fig. 1). The
contralateral testis and epididymis were normal.
We did not ﬁnd any abnormality in the results of the blood and
urine laboratory tests. We did not perform tests for testis tumor
markers such as alpha fetoprotein or human chorionic gonado-
tropin, because there were no ﬁndings that suggested a testicular
tumor.
At ﬁrst, we assumed that the growing right epididymal mass
was atypical epididymitis and planned to perform right epi-
didymectomy. Using a standard inguinal incision, right scrotal
explorationwas performed. We made an incision on the right testis
and opened the tunica vaginalis. A tortuous mass was observed in
the epididymis. It was well separated from the testis, but several
adhesions that attached the mass to the connective tissue around
the epididymis were observed. Therefore, we changed the treat-
ment plan to radically excise the epididymis from the testis. The
biopsy specimenwas reviewed by a pathologist. A solitarymasswas
observed in the gross specimen, which was separated from the
testicular capsule by a distance of 0.1 cm. The mass arose from the
epididymis and did not have a deﬁnite capsule. It appeared to have
invaded the surrounding soft tissues, but not the testis. Light mi-
croscopy revealed that histologically the specimen appeared to be a
malignant lymphoma, consisting of diffuse large B-cellnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Color Doppler ultrasonography of the right scrotum.
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tive for vimentin and leukocyte common antigen, and diffusely
positive for the CD20 antigen (Fig. 2).
We performed computed tomography for the chest, abdominal
and pelvic region, and neck, along with brain magnetic resonance
imaging, cerebrospinal ﬂuid analysis, bone marrow examination,
and ﬂudeoxyglucose-positron emission tomography for the staging
work-up. However, we did not ﬁnd the involvement of any other
tumor. The patient was referred to the Hemato-oncology Depart-
ment and was administered noeadjuvant chemotherapy combined
with radiotherapy. Rituximab along with cyclophosphamide,
doxorubicin, vincristine, and prednisone as well as intrathecalFigure 2. Immunohistochemistry asmethotrexate six cycles was performed. Radiotherapy was given in
seventeen times, with total 30.6 GY dose. Patient still showed no
evidence of disease state in 6 months follow-up after treatment.
Discussion
Diffuse large B-cell lymphoma (DLBCL) is themost common type
of non-Hodgkin lymphoma, which is commonly found in male
patients8 and its incidence increases with age. DLBCL typically
presents with a rapidly growing symptomatic mass, usually com-
bined with lymph node enlargement in the neck or abdomen.
Thirty percent of patients with DLBCL show systemic B symptoms,say of right epididymal tumor.
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lymphomas disseminate from an extra-testicular site; primary
lymphomas in the scrotal area comprise only 1e2% of all lymphoma
cases. Lymphomas localized in the epididymis are even rarer with
only a few cases reported.2e7
Schned et al2 reported the ﬁrst case of primary epididymal
lymphoma in a 26-year-old man, with no evidence of extra-
epididymal spread after extensive staging work-up. There was no
clinical evidence of disease 8 months after orchiectomy and
radiotherapy. Heaton and Morales3 described a primary histiocytic
lymphoma of the epididymis in a 73-year-old man. The lymphoma
was conﬁned to the right epididymis and initially showed a
decrease in size with antibiotic therapy. However, the tumor grew
in size after 1 year, and therefore, the patient was treated with
orchiectomy and post-operative radiotherapy. This patient showed
no evidence of disease 12 months after the treatment.
In 1993, Ginaldi et al4 reported a 7-cm high-grade DLBCL in the
epididymis of a 68-year-old-man who was treated with combined
orchiectomy and chemotherapy; however, he died 12 months later.
McDermot et al5 described a primaryDLBCL limited to the epididymis
of a 34-year-old man who initially presented with right epididymal
thickening and suspected with tuberculosis. Biopsy showed atypical
lymphoproliferative process in the epididymis, and there was no
involvement of any other site. Three months later the contralateral
epididymis required radical orchiectomy. After chemotherapy, the
patient showed no evidence of disease after 79 months.
Kaush et al6 and Novella et al7 reported primary DLBCL in the
epididymis of young men. The patients were treated with only
orchiectomy or orchiectomy combined with chemotherapy and
they showed no evidence of disease 36months and 18months after
treatment, respectively.
Our patient presented with epididymal enlargement that did
not respond to antibiotic therapy. We performed orchiectomy and
additional chemotherapy, after pathological examination. Asprimary DLBCL is not a common disease, there is no consensus
regarding optimal treatment. However, a review of previous case
reports of patients treatedwith chemotherapy or radiotherapy after
orchiectomy showed that it had good results. This patient also
showed no evidence of disease state in 6 months after surgery, but
still need pay attention for disease progression.
Conclusion
A primary DLBCL is rare condition, it only reported several cases.
Most of patients complained painless growing mass in epididymis.
It is important to rule out atypical malignant conditions of the
epididymis in patients who do not respond to antibiotic therapy.
And optimal treatment strategy set up for primary malignancy in
epididymis should be needed.
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